Skip to main content

Animations

MJFF Publications

801 - 810 of 8399 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • RESTRICTED
    Title: An analysis of data leakage and generalizability in MRI based classification of Parkinson's Disease using explainable 2D Convolutional Neural Networks
    Journal Name: Digital Signal Processing
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.dsp.2024.104407
    Best OA location URL:
    Citation Count: 7
  • RESTRICTED
    Title: Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000208033
    Citation Count: 8
  • OPEN
    Title: Racial disparities in hospitalization characteristics among Native Hawaiians, Pacific Islanders and Asian American subgroups with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106018
    Citation Count: 2
  • OPEN
    Title: Role of the LRRK2 C-terminal tail in domain crosstalk
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20230477
    Best OA location URL:
    Citation Count: 1
  • OPEN
    Title: 3D bioprinting of human neural tissues with functional connectivity
    Journal Name: Cell Stem Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.stem.2023.12.009
    Citation Count: 29
  • OPEN
    Title: A 3′UTR Insertion Is a Candidate Causal Variant at the TMEM106B Locus Associated With Increased Risk for FTLD-TDP
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000200124
    Citation Count: 2
  • RESTRICTED
    Title: A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00405-2
    Best OA location URL:
    Citation Count: 85
  • OPEN
    Title: A structural pathway for class III PI 3-kinase activation by the myristoylated GTP-binding pseudokinase VPS15
    Journal Name: Biophysical Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.bpj.2023.11.384
    Citation Count: 1
  • OPEN
    Title: Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity
    Journal Name: Cell Reports Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.crmeth.2024.100712
    Best OA location URL:
    Citation Count: 3
  • RESTRICTED
    Title: Mapping the human brain proteome: opportunities, challenges, and clinical potential
    Journal Name: Expert Review of Proteomics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14789450.2024.2313073
    Best OA location URL:
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.